skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Antihypertensive effects of astaxanthin

Expert Opinion

(3857) Views  (1086) Full article downloads

Authors: Hidekatsu Yanai, Kumie Ito, Hiroshi Yoshida, Norio Tada

Published Date October 2008 Volume 2008:1 Pages 1 - 3
DOI: http://dx.doi.org/10.2147/IBPC.S4094

Hidekatsu Yanai1,2, Kumie Ito1,2, Hiroshi Yoshida2,3, Norio Tada1,2

1Department of Internal Medicine; 2Institute of Clinical Medicine and Research; 3Department of Laboratory Medicine, The Jikei University School of Medicine, Chiba, Japan

Abstract: Astaxanthin is a biological antioxidant naturally found in a wide variety of aquatic living organisms, and has shown various pharmacological activities, such as anti-inflammatory and antidiabetic activities. A recent study reported that the administration of astaxanthin induced a significant reduction in blood pressure and delayed the incidence of stroke in stroke-prone spontaneously hypertensive rats, suggesting that astaxanthin also has antihypertensive effect. In a study using aortic rings of spontaneously hypertensive rats, astaxanthin induced a significant reduction of the contractile responses of the aorta to α-adrenergic receptor agonist and angiotensin II, which may contribute to the antihypertensive effect of astaxanthin. In a histopathological study, astaxanthin decreased coronary artery wall thickness compared with the control, indicating the possibility that astaxanthin ameliorates hypertension-induced vascular remodeling. Astaxanthin has anti-inflammatory, antidiabetic, antihypertensive, and antioxidative activities; therefore, we should perform further studies to elucidate an antiatherogenic effect of astaxanthin.

Keywords: astaxanthin, antioxidant, antihypertensive effect, atherosclerosis






 

Other articles by Dr Hidekatsu Yanai



Readers of this article also read:

Hemipelvic osteomyelitis in a hemodialysis patient associated with methicillin-resistant Staphylococcus aureus bacteremia
Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study
Cuff inflation during ambulatory blood pressure monitoring and heart rate
Postoperative pulmonary embolism in a three year old with Klippel–Trenaunay syndrome
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors
Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design
Intravesical foreign bodies: a case report and a review of the literature
A case of recurrent bloody tears
Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University